BackCryo-Cell International Overview
Cryo-Cell International, Inc.

Cryo-Cell International Debt to Equity

Valuation check: CCEL's debt-to-equity ratio is -0.63, above the Healthcare sector average of -8.5.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

-0.63

Debt to Equity

-0.63

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Cryo-Cell International (CCEL) FAQ

As of the most recent data, CCEL shows a debt-to-equity ratio of -0.63. That is above the Healthcare sector average of -8.5. Scroll down for historical charts and peer comparison views.

The Healthcare sector average debt-to-equity ratio is about -8.5. Cryo-Cell International is at -0.63, which is higher that average. That is roughly 92.6% above the sector mean. Use the comparison chart on this page to see how CCEL stacks up against individual peers as well.

Investors watch CCEL's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Cryo-Cell International's latest reading is -0.63. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Cryo-Cell International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently -0.63) with ownership activity and broader fundamentals.

The Healthcare average debt-to-equity ratio is about -8.5, while CCEL is at -0.63. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.